Work

Abstract 2437: Engineered human monoclonal antibodies targeting the Mullerian inhibiting substance type II receptor for ovarian cancer therapy

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-2437

Authors: Tatiana A. Karakasheva, Heidi H. Simmons, Stephen I. Rudnick, Matthew K. Robinson, Gregory P. Adams

Institution: Fox Chase Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2073482926

Cites:

Cited by:

Related to: 10